Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01195831Phase 3Completed
Phase 3, randomised, single-blind trial of calcipotriol + betamethasone in psoriasis, sponsored by LEO Pharma. Primary endpoint: Investigator's Global Assessment Success at 4 weeks. Started Sep 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01195831.